R1 RCM Inc (RCM):企業の財務・戦略的SWOT分析

◆英語タイトル:R1 RCM Inc (RCM) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15772
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

R1 RCM Inc (RCM) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

R1 RCM Inc (R1), formerly Accretive Health Inc is a healthcare solutions company that offers revenue cycle management (RCM) and physician advisory services (PAS). The company’s RCM services comprise, bill preparation and collections, patient registration, medical treatment documentation and coding, insurance and benefit verification. Its PAS offering helps hospitals and medical facilities in complying with payer requirements such as whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes. The company serves community healthcare systems, faith-based healthcare systems, ambulatory clinics, academic medical centers, physician practice groups and other healthcare organizations. R1 is headquartered in Chicago, Illinois, the US.

R1 RCM Inc Key Recent Developments

Feb 22,2019 R1 RCM reports fourth quarter and full year 2018 results
Feb 08,2019 R1 develops technology and innovation center in collaboration with Intermountain Healthcare
Feb 07,2019 R1 RCM to Release Fourth Quarter 2018 Results on February 22
Nov 07,2018 R1 RCM reports third quarter 2018 results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
R1 RCM Inc – Key Facts
R1 RCM Inc – Key Employees
R1 RCM Inc – Key Employee Biographies
R1 RCM Inc – Major Products and Services
R1 RCM Inc – History
R1 RCM Inc – Company Statement
R1 RCM Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
R1 RCM Inc – Business Description
R1 RCM Inc – SWOT Analysis
SWOT Analysis – Overview
R1 RCM Inc – Strengths
R1 RCM Inc – Weaknesses
R1 RCM Inc – Opportunities
R1 RCM Inc – Threats
R1 RCM Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Recent Developments
Feb 22, 2019: R1 RCM reports fourth quarter and full year 2018 results
Feb 08, 2019: R1 develops technology and innovation center in collaboration with Intermountain Healthcare
Feb 07, 2019: R1 RCM to Release Fourth Quarter 2018 Results on February 22
Nov 07, 2018: R1 RCM reports third quarter 2018 results
Nov 06, 2018: R1 Announces Collaborative Partnership with Robotic Process Automation Technology Leader Automation Anywhere to Enhance Revenue Cycle Management
Oct 22, 2018: R1 Expands Physician Practice Footprint with CarePoint Health and Holston Medical Group
Aug 09, 2018: R1 RCM reports second quarter 2018 results
Jun 25, 2018: Amita Health Selects R1 Rcm For End-To-End Revenue Cycle Management
May 09, 2018: R1 RCM Reports First Quarter 2018 Results
Apr 23, 2018: Beacon Health Selects R1 RCM for Expanded Revenue Cycle Services
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
R1 RCM Inc, Key Facts
R1 RCM Inc, Key Employees
R1 RCM Inc, Key Employee Biographies
R1 RCM Inc, Major Products and Services
R1 RCM Inc, History
R1 RCM Inc, Subsidiaries
R1 RCM Inc, Key Competitors
R1 RCM Inc, Ratios based on current share price
R1 RCM Inc, Annual Ratios
R1 RCM Inc, Annual Ratios (Cont...1)
R1 RCM Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
R1 RCM Inc, Performance Chart (2014 - 2018)
R1 RCM Inc, Ratio Charts

★海外企業調査レポート[R1 RCM Inc (RCM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CellaVision AB (CEVI):医療機器:M&Aディール及び事業提携情報
    Summary CellaVision AB (CellaVision) is a medical technology company that provides digital solutions for medical microscopy in hematology. The company helps hematology laboratories improve and transform the analysis of blood and other body fluids. It has expertise in digital image analysis, automate …
  • Dowa Holdings Co., Ltd.:戦略・SWOT・企業財務分析
    Dowa Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dowa Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Collegium Pharmaceutical Inc (COLL):医療機器:M&Aディール及び事業提携情報
    Summary Collegium Pharmaceutical Inc (Collegium) is a specialty pharmaceutical company that focuses on the development and commercialization of innovative products for treating patients suffering from pain. The company develops products based on its DETERx platform technology. DETERx offers extended …
  • Biolife Solutions Inc (BLFS):企業の財務・戦略的SWOT分析
    Summary BioLife Solutions Inc (BioLife Solutions) is a developer, manufacturer and supplier of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media for cells and tissues. The company offers serum-free and protein-free solutions, which are formulated to red …
  • Orly International, Inc.:企業の戦略・SWOT・財務分析
    Orly International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Orly International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Global Clean Energy Holdings Inc (GCEH):企業の戦略的SWOT分析
    Global Clean Energy Holdings Inc (GCEH) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • AMO Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary AMO Pharma Ltd (Amo Pharma) is a biopharmaceutical company that develops novel treatments for serious and debilitating diseases. The company provides pipeline product portfolio such as AMO-01, and AMO-02. Its AMO-01 is being developed for the treatment of autism and intellectual disabilities …
  • J.F. Shea Co Inc:企業の戦略・SWOT・財務情報
    J.F. Shea Co Inc - Strategy, SWOT and Corporate Finance Report Summary J.F. Shea Co Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Willis Lease Finance Corp (WLFC):企業の財務・戦略的SWOT分析
    Willis Lease Finance Corp (WLFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Universal Hospital Services Inc:医療機器:M&Aディール及び事業提携情報
    Summary Universal Hospital Services Inc (UHS) is a clinical equipment service company that offers medical equipment management and service solutions. The company offers equipment services and equipment rental services. Its equipment services include clinical engineering, on-site management, surgical …
  • TransAlta Corp (TA):電力:M&Aディール及び事業提携情報
    Summary TransAlta Corp (TransAlta) is an electricity generation company. It owns, operates and develops a divergent fleet of electricity generation assets. It generates electricity from a contracted portfolio of assets using diverse sources such as coal, natural gas, hydro, wind and geothermal. Tran …
  • Revance Therapeutics Inc (RVNC)-医療機器分野:企業M&A・提携分析
    Summary Revance Therapeutics Inc (Revance Therapeutics) develops, manufactures and commercializes novel botulinum toxin products. The company’s product candidate includes RT002, an injectable formulation of botulinum toxin type for the treatment of glabellar lines, cervical dystonia, and plantar fas …
  • Seair Inc:企業の戦略的SWOT分析
    Seair Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Abcam Plc (ABC):製薬・医療:M&Aディール及び事業提携情報
    Summary Abcam Plc (Abcam) is a supplier of life science research tools for analysis of living cells at molecular level to understand a wide range of disease conditions. The company develops and markets antibodies and other related products. Its product portfolio includes primary antibodies, secondar …
  • Spectral Medical Inc (EDT):医療機器:M&Aディール及び事業提携情報
    Summary Spectral Medical Inc (Spectral), formerly Spectral Diagnostics Inc, is a biotechnology company that develops and commercializes diagnostic solutions for patient management. The company’s products comprise EAA, toraymyxin and reagents, among others. Its EAA is an endotoxin activity assay, whi …
  • Hemanext:医療機器:M&Aディール及び事業提携情報
    Summary Hemanext, formerly New Health Sciences Inc, is a medical technology company that develops blood storage systems. The company offers an anaerobic storage system that minimizes oxidative damage to red blood cells in storage and delivers physiologic, therapeutic, and fresher red blood cell than …
  • EL Sewedy Electric Co (SWDY):企業の財務・戦略的SWOT分析
    EL Sewedy Electric Co (SWDY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • PellePharm Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PellePharm Inc (PellePharm), a subsidiary of BridgeBio Inc, is a biotechnology company that develops and commercializes treatments for rare genetic dermatological conditions. The company’s lead clinical program, Patidegib, is a first-in-class topical gel formulation of a proprietary hedgehog …
  • Perstorp Holding AB:企業の戦略的SWOT分析
    Perstorp Holding AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Cofidis Participations S.A.
    Cofidis Participations S.A. - Strategy, SWOT and Corporate Finance Report Summary Cofidis Participations S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆